Supreme Court Temporarily Restores Access to Abortion Pill Mifepristone
The Supreme Court has restored access to mifepristone, an abortion pill, by blocking a lower court ruling that imposed restrictions. Mifepristone, often used with misoprostol, constitutes a major abortion method. Legal battles continue as debates over safety and access unfold, impacting abortion laws across states.
The Supreme Court has temporarily restored broad access to the abortion pill mifepristone, halting a lower court's decision that could have dramatically altered abortion provision across the nation. Justice Samuel Alito signed the order, allowing women to obtain the drug at pharmacies or through mail without physician visits, maintaining current rules while the court deliberates further.
Telehealth abortions have become a significant method in states with strict abortion laws, especially following the 2022 Roe v. Wade ruling reversal. Despite ongoing legal challenges questioning mifepristone's safety, providers switched to misoprostol-only prescriptions, although this alternative also faces scrutiny and logistical challenges in delivery.
Legal experts emphasize that the court's decision does not criminalize accessing abortion care. The legal fight continues as anti-abortion groups and states push for stricter regulations, questioning the FDA's policies, with ongoing developments closely watched by providers and activists nationwide.
(With inputs from agencies.)
ALSO READ
Eateries must mention 'cheese analogue' on menu cards, receipts if used in food: FDA order
Tukaram Mundhe appointed as FDA Commissioner
Upheaval at the FDA: Leadership Changes Amid Controversy
Shake-Up at FDA: Tracy Beth Hoeg Expected to Leave Amid Vaccine Policy Controversy
Shake-Up at FDA: Uncertainty as Key Leader Departs
Google News